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Abstract
BACKGROUND: Conflicting results have been published con-
cerning the reproducibility of Tc-99m MAG3 clearance.
The aim of the study was to reevaluate again this reproducibi-
lity on a large prospective series of healthy volunteers.
MATERIAL AND METHODS: Fifty subjects underwent three
successive tests performed at 1-week interval. The physiological
conditions were controlled as much as possible and all experi-
mental measurements were rigorously double-checked. Renal
clearances were calculated using single sample algorithms.
RESULTS: Thin layer chromatography demonstrated a radio-
chemical purity of more than 92% (mean 93.8%; SD 1.6%; range
92.0–96.4%). The mean (and SD) of 44th minute plasma con-
centrations for the three successive measurements were respec-
tively 1.8 ± 0.4, 2.1 ± 0.4 and 1.9 ± 0.4 (%dose/liter). The mean
changes (and S.D. of differences) between two tests were 0.26 ±
± 0.29, –0.08 ± 0.5 and 0.18 ± 0.30 respectively between tests
1 and 2, tests 1 and 3, and tests 2 and 3.
Using Bubeck’s algorithm, the mean clearance values (ml/min/
/1.73 m²) were 268.8 (range 201.4–336.8), 247.2 (range 170.5–
–290.3), and 262.8 (range 187.4–340.0) respectively for the first,
second and third measurements. Using Russell’s approach, the
mean clearance values were respectively 314.9 (range: 208.7–441.7),
280.1 (range: 167.5–358.6), and 305.4 (range: 189.5–447.9).
CONCLUSIONS: High differences were observed between the
3 tests. Using Russell´s formula, the SD of differences between
two tests was respectively 35.8, 47.7 and 57.7 ml/min/1.73 m2
between tests 1 and 2, tests 1 and 3, and tests 2 and 3. Whe-
ther such a large variability is acceptable in clinical practice
depends solely on what the clinician is expecting.
Key words: Tc-99m MAG3, clearance, precision,
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Introduction
Because of its high extraction rate and its excellent imaging
properties [1–6], Tc-99m MAG3 is considered by many as the
tracer of choice for renography. On the other hand, the use of this
tracer for evaluating renal clearance remains controversial. Indeed,
to be useful, the measurement of clearance should be reproducible.
In this respect, conflicting results have been published [7–12].
Some authors [8, 10–12] have found a good reproducibility while
others [7, 9] reported rather bad results.
The purpose of the present study was to reevaluate this intra-
individual reproducibility on a large prospective series of normal
volunteers, who underwent three successive tests, performed at
1-week interval. The physiological conditions of the subject were
controlled as much as possible and all experimental measure-
ments were rigorously double-checked.
Material and methods
Volunteers
Fifty healthy volunteers (19 males, 31 females) were enrolled
in this study. They had a mean age of 29 years and a median age
of 25 years (range 18–56 years).
They had no previous history of renal disease and their blood
pressure was normal. None of them was receiving any medication.
The local ethical committee approved this study and written
informed consent was obtained from all subjects prior to the exa-
minations.
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The fifty volunteers underwent three successive tests, all per-
formed in the morning at 1 week interval. They had a light break-
fast prior to the investigation and were asked to have the same
breakfast for the three consecutive tests. At arrival in the depart-
ment, they were extra hydrated with 33 cc. of water half an hour
prior to the tracer injection and another 33 cc. of water between
the tracer injection and the blood sampling.
The volunteers remained sitting in the department until the
end of the plasma sampling (44 min. after injection).
The whole procedure was then repeated one week and two
weeks later under exactly the same physiological conditions.
Each volunteer was injected approximately at the same hour
for the three successive tests.
Tracer, dose, standard
Tc-99m MAG3 was prepared just before administration, in
accordance with the recommendations of the manufacturer,
using freshly eluted Tc-99m-sodium pertechnetate from a commer-
cial Mo-99/Tc-99m generator (Ultratechnekow FM, Tyco Mallinck-
rodt Medical, Petten, Holland). All the doses prepared for the three
consecutive tests were issued from the same batches (Technes-
can MAG3, Tyco Mallinckrodt Medical, Holland). For each of the
three tests, two Tc-99m MAG3 preparations were used in order to
shorten the time interval between preparation and injection. For each
preparation, two standards of the dose were prepared.
Immediately after each of the six labeling procedures, quality
control of Tc-99m MAG3 was performed by thin-layer chromatog-
raphy (TLC). The same investigator was in charge of all the label-
ing procedures, measurements and in vitro counting, under the
supervision of the radiopharmaceutical company.
The dose and a standard of the dose were weighed with an
accuracy of 0.1 mg.
The standard and the post-injection residue of the dose were mea-
sured at a constant distance from the gamma camera; the ratio of these
two measurements was used to estimate the weight of the residue.
Injection of the tracer
Each volunteer received an intravenous injection of 18 MBq
Tc-99m MAG3 — diluted up to 2 ml — using a Butterfly needle
and a three-way system, and rapidly flushed twice with 10 ml sa-
line. The injection was always performed by the same investigator.
After the injection, the arm was positioned in front of a gamma
camera in order to detect any extra vascular escape of the tracer
at the time of the intravenous injection.
The same amount of activity was injected for the three con-
secutive tests.
Radio waved synchronized clocks were used in order to mi-
nimize the error on indicating the time of injection and the time of
blood sampling.
Blood sampling
One blood sample was drawn from the antecubital vein oppo-
site to the injection site at 44 min. after tracer injection. The blood
sampling was always performed by the same investigator.
Counting
A 1 ml aliquot of the standard and the serum sample were
measured in duplicate in a well counter for 1 minute, with a statis-
tical error of < 1%.
Empty tubes were inserted among the samples for estimating
background count rates and a correction was introduced for
Tc-99m decay.
Clearance calculation
For the clearance determinations, two different algorithms were
used: Bubeck´s formula, in which the plasma concentration is
first corrected for body surface [6]; and Russell´s formula, in which
the correction for body surface is introduced on the calculated
clearance value [3].
Bubeck’s formula:
Tc-99m MAG3 clearance = a + b ln(ID/Cnt) [ml/min/1.73m²]
Where: a = –517 e-0.011.t; b = 295 e-0.016.t; ID = injected activity
(cps); Cn = C × BS/1.73 m² = normalized plasma concentration
(cps/l); C = plasma concentration (cps/l); BS (body surface) =
= 10^(LOG(W)*0.425 + LOG(L) *0.725–2.144); t = time of blood
sampling post-injection [min]; W = weight [kg]; L = length [cm].
Russell’s formula:
Tc-99m MAG3 clearance = Fmax (1 – (exp(-a(1/c – Vlag))) [ml/min]
Where: c — fraction of dose per liter of plasma [l–1]; T — time
between injection and withdrawing of sample, between 35–55 min
[min]; Fmax = 0.0400 t²–8.20 t + 915; a = 6.50 . 10
-6 t²–8.60 . 10-4
t + 3.91 . 10-²; Vlag = –0.00150 t² + 0.0100 t + 8.79.
The result is then corrected for body surface.
Reproducibility
The reproducibility was assessed according to the procedure
published by Bland and Altman [13].
The mean of the individual differences represented the sys-
tematic difference between the two measurements. The standard
deviation of these differences represented the reproducibility (pre-
cision) of the technique.
A paired t-test was used to evaluate differences between the
different measurements. Bonferoni correction was used to take
into account the multiple comparisons.
Moreover, in order to evaluate the effect of the Tc-99m MAG3
preparations on the reproducibility, the volunteers were also strat-
ified according to the moment of the test: group A patients
(n = 19) were those who received for the three tests an early
morning Tc-99m MAG3 preparation; group B patients (n = 15)
were those who received for the three tests a late morning prepa-
ration; group C patients (n = 13) were those with irregular time
schedule: early morning test on one day and late morning on an-
other day.
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Results
Radiochemical purity
TLC demonstrated a mean radiochemical purity of more than
92.0% on the six labeling procedures of MAG3 with Tc-99m (mean:
93.8%; S.D.: 1.6%; range: 92.0–96.4%). Free Tc-99m pertechne-
tate and impurities respectively amounted to 3.40 ± 0.99% and
2.76 ± 0.68%.
Exclusions
Among the 50 volunteers, three were excluded because they
missed one appointment. No particular event (disease, emotional
stress, and medication) occurred among the volunteers during
the whole duration of the study.
In no case could significant local uptake at the place of injec-
tion be detected. Therefore, 47 sets of consecutive clearance data
remained for comparison.
Reproducibility of TC-99m MAG3 clearance
Plasma concentration
The mean plasma values were respectively 1.8 ± 0.4, 2.1 ±
± 0.4 and 1.9 ± 0.4 (%dose/L) for the first, second and third test
(Table 1). The plasma concentrations were higher (p < 0.001) for
the second study than for the first or the third one, independently
of the fact that the MAG3 preparation was an early morning one or
a late morning one.
The mean changes (and SD of differences) between two tests
were 0.26 ± 0.29, –0.08 ± 0.5 and 0.18 ± 0.30 respectively be-
tween tests 1 and 2, tests 1 and 3, and tests 2 and 3.
MAG3 clearance
The mean and SD of the clearance values are reproduced in
Table 2, for the three successive measurements and the two di-
fferent algorithms for clearance calculation.
Using Bubeck’s method, the mean clearance value was re-
spectively 268.8 ml/min/1.73 m² (range: 201.4–336.8), 247.2 ml/
/min/1.73 m² (range: 170.5–290.3), and 262.8 ml/min/1.73m²
(range: 187.4–340.0) for the first, second and third measurements.
Using Russell’s approach, the mean clearance value was re-
spectively 314.9 ml/min/1.73 m² (range: 208.7–441.7), 280.1 ml/
/min/1.73 m² (range: 167.5–358.6), and 305.4 ml/min/1.73m²
(range: 189.5–447.9) for the first, second and third measurements.
The MAG3 clearance was significantly lower on the second
test (p < 0.001), compared to the first and third tests, for both
Russell´s and Bubeck´s algorithms. No such differences were
observed between the first and third tests.
The mean changes and the SD are reported in Table 2, and
Figure 1 shows the Bland and Altman plot of individual differ-
ences.
Table 1. Mean plasma values according to the moment at which the volunteers were injected
Mean plasma value Difference
n 1 2 3 2–1 3–2 3–1
A 19 Mean [%dose/L] 1.9 2.0 1.9 0.1 –0.1 –0.1
SD [%dose/L] 0.3 0.3 0.4 0.2 0.3 0.3
B 15 Mean [%dose/L] 1.7 2.1 2.0 0.4 –0.2 0.3
SD [%dose/L] 0.4 0.5 0.4 0.2 0.4 0.3
C 13 Mean [%dose/L] 1.8 2.2 1.9 0.3 –0.3 0.1
SD [%dose/L] 0.3 0.5 0.5 0.3 0.2 0.4
All 47 Mean [%dose/L] 1.8 2.1 1.9 0.3 –0.1 0.2
SD [%dose/L] 0.4 0.4 0.4 0.3 0.5 0.3
Group (A) corresponds to those who received on the three days early morning Tc-99m MAG3 preparation; group (B) are those who received on the three days a late morning
preparation; group (C) are those with irregular time schedule: early morning test on one day and late morning on another day; 1, 2, and 3 are the plasma values respectively for the
first, second, and third measurements
Table 2. Mean clearance values according to Bubeck’s and Russell’s formulae
Mean clearance value Difference
n 1 2 3 2–1 3–2 3–1
Russell 47 Mean [ml/min/1.73m2] 314.9 280.1 305.4 –34.8 25.3 –9.5
SD [ml/min/1.73m2] 52.9 43.2 53.4 35.9 47.7 57.7
Bubeck 47 Mean [ml/min/1.73m2] 268,8 247.2 262.8 –21.6 15.6 –6.0
SD [ml/min/1.73m2] 30,7 26.7 30.5 21.9 23.4 30.3
1, 2, and 3 are the plasma values for respectively the first, second, and third measurement
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Figure 1. Bland and Altman plot. A. Comparison between the results of second and first tests. The abcis indicates the mean clearance value of the two
tests. The ordinate shows the difference between the same two tests. The results obtained using Bubeck’s algorithm are represented by open circles and
those using Russell’s algorithm by closed circles. The magnitude of differences for the individual subjects can be appreciated. The numerical values for
the whole groups are presented in Table 2; B. Comparison between the results of third and first tests. The abscise indicates the mean clearance value of
the two tests; C. Comparison between the results of third and second tests. The abscise indicates the mean clearance value of the two tests.
adults [1–6]. Most publications are either comparing Tc-99m MAG3
clearance with the excretion of other renal tracers [1, 2] or dealing
with the determination of simplified clearance algorithms in chil-
dren and adults [3–6].
However, since the purpose of clearance measurement is to
appreciate any change of function related to disease or treatment,
a good day-to-day reproducibility is required. This has recently
been the focus of debate.
Theoretically, a proper evaluation of clearance reproducibility should
be evaluated on subjects not suspected of having any disease which
might result in improvement or deterioration of renal function.
Therefore, preference should be given to prospective investi-
gations on human volunteers, not affected by any disease and in-
vestigated in well-controlled physiological conditions, rather than
to bias-prone retrospective selection of patients. Moreover, the most
accurate technique of clearance measurement should be applied.
Using the biexponential fit on multiple blood samples taken from
12 healthy volunteers, Piepsz et al [7] found a poor reproducibility
of MAG3 clearance compared to a good Cr-51 EDTA clearance
reproducibility. Moreover, they observed a systematic bias, the clear-
ance values observed during the first measurement being signifi-
cantly lower than those observed during the second measurement.
For all three tests, the coefficients of variation were smaller
using Bubeck´s algorithm than using Russell´s algorithm.
Using Bubeck’s algorithm, the mean changes were –21.6 ml/
/min/1.73 m² (SD: 21.9 ml/min/1.73 m²) between the second and
first test, 15.6 ml/min/1.73 m² (SD: 23.4 ml/min/1.73 m²) between
the third and second test, and –6.0 ml/min/1.73 m² (SD: 30.3 ml/
/min/1.73 m²) between the third and first test.
Comparison of the results obtained by Russell’s approach
showed a mean difference of –34.8 ml/min/1.73 m² (SD: 35.9 ml/
/min/1.73 m²) between the second and first test, a mean differ-
ence of 25.3 ml/min/1.73 m²(SD: 47.7 ml/min/1.73 m²) between
the third and second test, and a mean difference of –9.5 ml/min/
/1.73 m² (SD: 57.7 ml/min/1.73 m²) between the third and first test.
Discussion
Tc-99m MAG3 is mainly excreted in the urine by tubular se-
cretion. Because of its high extraction rate and the resultant high-
er signal-to-noise ratio, it is presently widely employed for gamma
camera renography.
The determination of MAG3 plasma clearance by means of
blood samples has also been advocated in children as well as in
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Referring to previous animal experiments and human studies
[14–16], the authors postulated that a stress factor, related to the
heavy methodology they were using, might have induced the ini-
tial low clearance values they observed.
Further studies, using different approaches, appeared later
on: retrospective studies on patients [10–12] or prospective in-
vestigations on volunteers [8]; single sample [9–11] or two-sam-
ple plasma clearance [8]; clearance calculation by means of slope
intercept method [8], Bubeck’s [9–10] or Russell’s [11] algorithms.
The variability observed was between 12 and 40 % with [7–9] or
without [10] a systematic difference between the successive clear-
ance determination. Depending on the authors, acceptable [8, 10–
–12] or unacceptable [7, 9] reproducibility was the final conclusion.
Because of these conflicting results, it was decided to start
a new prospective experiment on a large number of healthy vo-
lunteers, in rather strictly determined physiological conditions
(same hour of tracer injection, similar state of hydration, protein
load and level of physical activity). In order to minimize as much
as possible the stress factor related to an unknown procedure as
postulated in previous studies [8–11], the simplified one blood
sample technique was chosen. Moreover, it was decided to re-
peat three times the whole procedure, considering that the poten-
tial stress factor would preferentially affect the first measurement.
In this type of study, quality control at the various steps of the
methodology is essential. The purity of the MAG3 preparations
was systematically checked and was considered as acceptable
according to the specifications of the manufacturer. Moreover, in
order to detect any systematic difference related to an imperfect
preparation, two preparations were used for each of the three ex-
perimental mornings.
Another factor that might significantly affect the result of the
clearance is the measurement of the injected dose, standard, di-
lution of the standard and plasma samples. Therefore, the same
experienced technologist performed these measurements and
introduced elements allowing a quality control: samples measured
in duplicate; measurement of dose and standard using a high
precision balance.
Because of the large number of clearance measurements
performed each day, a team of 9 people (medical and technical
staff) participated to the study at different steps of the investiga-
tion (checking recent history of disease or stress, intravenous in-
jection, checking of the possible paravenous injection, blood sam-
pling). Radio waved synchronized clocks were also used, since
errors in estimating the time interval between tracer injection and
blood sampling may significantly affect the result of the clearance.
Finally, it was decided to apply the single sample algorithm
proposed by Russell [3] for the calculation of MAG3 clearance. It
has indeed been shown [17] that this technique provides results
which are highly correlated with the multiple blood sample tech-
nique taken as the reference. On the contrary, the results obtained
with Bubeck’s algorithm are less good, particularly for the normal
and high clearance range, where this algorithm clearly underesti-
mates the true values. As the present study concerned normal
volunteers, one could predict an artificial compression of the val-
ues at this clearance level using Bubeck’s algorithm. However,
since several studies on MAG3 reproducibility were based on this
last formula, it was decided to calculate clearance using both al-
gorithms, for the purpose of comparison.
The results show that the individual plasma concentrations
were significantly higher at the second examination than at the
first or the third examination. As a consequence of this, whatever
the algorithm used, the clearance values were significantly lower
during the second examination compared to the two others. The
reason for this systematic difference is unclear. Stress, as postu-
lated in previous studies [8–11], cannot explain the lower clea-
rance observed during the second test. Similarly, methodological
errors at the various steps of the procedure cannot be responsi-
ble for such a difference. Having in mind the possibility that such
a difference would occur, it was decided that, for each experi-
mental day, two different MAG3 preparations would be used. Since
each volunteer was generally tested around the same hour on the
three successive days, it was possible to classify the volunteers
according to the preparation they received (group A, B and C).
The analysis of these data clearly shows (Table 1) that the lower
clearance values observed during the second series of experi-
ments were not related to the MAG3 preparation, since the diffe-
rence was observed for both preparations of the day. We can only
introduce an additional hypothesis that the difference could be
related to the Mo-99/Tc-99m generator. We cannot exclude that,
despite having respected all the manufacturer’s recommendations,
some impurities due to the Mo-99/Tc-99m generator might have
affected both final preparations of the second day.
Table 3. Previous studies on the reproducibility of Tc-99m MAG3 clearance
Authors n Prospective/ Volunteers/ Number BS Method Time Mean (%) SD (%)
Retrospective Patients interval
Piepsz et al [7] 12 Prospective Volunteers 15 Biexponential 1 week –20.0 25.0
Kanazawa et al [8] 12 Prospective Volunteers 2 Slope-intercept 1 month –7.1 11.1
Kotzerke et al [9] 30 Prospective Patients 1 Bubeck < 1 day –2.0 6.3
Kotzerke et al [9] 30 Prospective Patients 1 Bubeck 1 week –16.0 40.4
Kotzerke et al [9] ** 27 Prospective Patients 1 Bubeck 1 week 6.0 15.7
Kotzerke et al [9] 30 Prospective Patients 1 Bubeck 1 year –1.5 11.7
Werner et al [10] 242 Retrospective Patients 1 Bubeck < 50 days –0.36 11.7
Russell et al [11] 197 Retrospective Patients 1 Russell Repeated Fit 12.0*
Measurements
Möller et al [12] 17 ? Patients ? ? 5 days ? 12.4
* combination of 2 tracers — use of a conversion factor MAG3 to Hippuran; ** only patients with  clearances > 100 ml/min were taken into account
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For both the plasma concentrations and the clearance results
obtained using Russell’s algorithm, the variability was between 12
and 18 %, depending on the combination of tests 1, 2 and 3, and
represents the true reproducibility of the MAG3 clearance. As ex-
pected, the variability observed with the Bubeck’s method was less,
but is due to an artificial compression of the clearance values [17].
Compared to the results previously observed using multiple
blood samples [7], the level of reproducibility is better. Compared
to the other studies on reproducibility, particularly those based on
Bubeck’s algorithm [9–10], the present results are at least as good
(Table 3).
In this study a variability of 15% is observed. Two factors should
be taken into account in interpreting the results. First, the present
results were obtained using a single sample method. The error
inherent to this method is included in the global results. Second,
these results were obtained in an almost ideal experiment, which
can not be reproduced in daily clinical practice.
The question arises whether a level of reproducibility around
15% is acceptable in clinical practice, knowing that two standard
deviations may represent a variability of 115 ml/min. The answer
is essentially depending on the expectations of the clinician.
If the aim is simply to obtain a gross estimate of the function
(normal, impaired, strongly impaired), then a difference of 50 to
100 ml/min is probably unimportant.
The problem is essentially different if the effect of a disease,
of a medication or a surgical treatment has to be estimated. In
pelviureteric junction stenosis, for instance, the surgical deci-
sion is often based on a 10% decrease of the unilateral function
[18]. It is clear that the level of reproducibility of MAG3 clearance
found by us as well as by most of the other authors does not
allow the use of Tc-99m MAG3 clearance for that purpose. Al-
though repeated measurements in a given patient will reason-
ably describe, on a long course, the general trend of the renal
function, the comparison of two successive tests is unable to esti-
mate accurately the evolution of the renal uptake between these
two successive tests.
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